• A case of acute lymphocytic gastritis related to treatment with pembrolizumab for metastatic urothelial carcinoma
• A Case of Mistaken Identity
• Acquired Ichthyosis Revealing Lymphocytic Colitis
• Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs)
• Are Drugs Associated with Microscopic Colitis? A Systematic Review and Meta-Analysis
• Atypical Presentations of Collagenous Gastritis Mimicking Celiac Sprue
• Benign Peptic Ulcer as a Cause of Gastrocolic Fistula
• Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing
• Biosimilars Use in Medicine for Inflammatory Diseases
• Biosimilars Use in Medicine for Inflammatory Diseases
• Case-control study of the concurrence of coeliac disease with inflammatory bowel disease
• Catechol-O-methyl-transferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's Disease
• Catechol-O-methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease
• Celiac disease and risk of microscopic colitis: A nationwide population-based matched cohort study
• Celiac Patient With New Episodes of Diarrhea: A Case Report
• Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors
• Chronic Lymphocytic Leukemia Causing Gastric Ulcer Perforation: A Case Presentation and Literature Review
• Clinical cases of microscopic colitis: Diagnosis and treatment issues. Case report
• Clinical Implications of Microscopic Colitis Isolated to Polyps
• Clinicopathologic Characterization of Lymphocytic Colitis in the Pediatric Population
• Colite lymphocytaire associée à l’entacapone
• Collagenous and Lymphocytic Colitis
• Collagenous and Lymphocytic Colitis
• Collagenous colitis following SARS-Cov2 mRNA vaccination
• Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance
• Concomitant Lymphocytic Colitis With Recurrent Clostridium difficile Infection
• Contrasting Autoimmune Comorbidities in Microscopic Colitis and Inflammatory Bowel Diseases
• Correction to "Lymphocytic colitis associated with entacapone"
• Current status of phosphoinotiside-3 kinase inhibitors in blood cancers
• Cutaneous IgG4-related disease associated with lymphocytic colitis
• Cytokine Release Syndrome-Associated Colitis: Insights From a Case of Rituximab-Induced Pancolitis
• De Novo Diagnosis of Lymphocytic Colitis After SARS-CoV-2 Vaccination
• Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care
• Drug Exposure and Risk of Microscopic Colitis: A Systematic Review and Meta-Analysis
• Editorial: type 1 diabetes, microscopic colitis and the need to explore the complex mechanisms of this association
• Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis
• Endogenous Levels of Circulating Androgens Are Not Associated with Risk of Microscopic Colitis
• Enterocolic lymphocytic phlebitis as a rare vascular cause of colitis
• Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country
• Epigenetic reader SP140 loss of function drives Crohn's disease due to uncontrolled macrophage topoisomerases
• Evaluation of Ki-67, goblet cell and MUC2 mucin RNA expression in dogs with lymphoplasmacytic and granulomatous colitis
• Factors associated with long-term clinical outcome in microscopic colitis
• Fecal calprotectin level in microscopic colitis: a systematic review and meta-analysis
• Frequency And Risk Factors Of Microscopic Colitis As A Cause Of Chronic Watery Diarrhoea
• Histologic manifestations of ocrelizumab-associated intestinal and hepatic injury in patients with multiple sclerosis
• HLA signatures as pathophysiological discriminants of microscopic colitis subtypes
• Host-related low-prevalence gastritides: Epidemiological and clinical characterization
• Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
• Idelalisib (PI3Kdelta inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients
• Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients
• Images in Vascular Medicine: Enterocolic lymphocytic phlebitis as a rare vascular cause of colitis
• Immune checkpoint inhibitor therapy associated enteritis mimicking celiac disease
• Immune checkpoint inhibitor-related colitis in patients on immunotherapy for cancer
• Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease
• Is mastocytic colitis a specific clinical-pathological entity?
• Late relapse of ulcerative colitis presenting as tracheobronchitis: a case report
• Lymphocytic "…itis", from esophagus to large bowel
• Lymphocytic "itis", from esophagus to large bowel
• Lymphocytic colitis associated with entacapone
• Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitis
• Lymphocytic colitis caused by medicine ingredient modification
• Lymphocytic Colitis With Enterocolic Lymphocytic Phlebitis
• Lymphocytic colitis with macroscopic findings
• Lymphocytic interstitial pneumonia in a patient with lymphocytic colitis
• Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib
• Mesenteric Lymphatic B Cells Migrate to the Intestine and Aggravate DSS-Induced Colitis via the CXCR5-CXCL13 Axis
• Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm
• Microbiome Composition in Microscopic Colitis: A Systematic Review
• Microscopic colitis found together with celiac disease in a female population is associated with one episode of lymphocytic colitis
• Microscopic colitis related to food supplement containing turmeric: a review of 3 cases
• Microscopic Colitis: A Diagnostic Challenge in Patients with Irritable Bowel Syndrome
• Microscopic Colitis: A Review Article
• Microscopic colitis: an update
• Microscopic colitis: Etiopathology, diagnosis, and rational management
• Microscopic Colitis: Pathogenesis and Diagnosis
• Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
• P073 Diagnostic Outcome of Patients With Non-Specific Colitis
• Patients With Microscopic Colitis Are at Higher Risk of Major Adverse Cardiovascular Events: A Matched Cohort Study
• Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma
• Prevalence of Atherosclerotic Disease in Microscopic Colitis Patients
• Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
• Proton pump inhibitors use and risk of inflammatory bowel diseases: a meta-analysis of observational studies
• Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies
• Reduced Intake of Dietary Tryptophan Improves Beneficial Action of Budesonide in Patients with Lymphocytic Colitis and Mood Disorders
• Refining the Concept of Microscopic Colitis: HLA Signatures Discriminating Collagenous and Lymphocytic Colitis
• Regional differences in the incidence of lymphocytic and collagenous colitis over time
• Rheumatologic associations of microscopic colitis: A narrative review
• Roth-like Spot in an Adult With Vitamin B₆ Deficiency and Nonepileptic Seizures
• SARS-CoV-2 as a potential trigger for microscopic colitis in a young adult: A case report
• Severe Hepatitis Complicating Olmesartan Enteropathy: A Case Report
• Th1 promotes M1 polarization of intestinal macrophages to regulate colitis-related mucosal barrier damage
• The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
• The association between drugs and repeated treatment with budesonide in patients with microscopic colitis: a retrospective observational study
• The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis
• The Metabolomic Profile of Microscopic Colitis Is Affected by Smoking but Not Histopathological Diagnosis, Clinical Course, Symptoms, or Treatment
• The natural history of histological changes in microscopic colitis
• The Utility of Fecal Calprotectin in the Diagnosis and Management of Microscopic Colitis
• Type 1 diabetes and microscopic colitis: A nationwide matched case-control study in Sweden
• What do we know today about drug-induced microscopic colitis? A case of lymphocytic colitis on olmesartan
• Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial